PREDICTIVE ONCOLOGY INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.34 USD | -11.25% |
|
+3.88% | -59.27% |
Presentation Operator MessageOperator (Operator)Greetings, and welcome to the Predictive Oncol...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Predictive Oncology Inc. is a knowledge-driven company focused on applying artificial intelligence (AI) to support the development of cancer therapies. The Company operates through three segments: Pittsburgh, Birmingham, and Eagan. Pittsburgh segment provides services, which include the application of artificial intelligence (AI) using its proprietary biobank of 150,000 plus tumor samples. Pittsburgh segment also develops tumor-specific in vitro models for oncology drug discovery and research. Birmingham segment focuses on contract services and research for biopharmaceutical company clients and academic collaborators, focused on solubility improvements, stability studies, and protein production. Specifically, Birmingham provides optimized formulations for vaccines, antibodies, and other protein therapeutics. Eagan segment produces the STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal.
Calendar
2024-05-13
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -59.27% | 6.13M | |
| -2.54% | 187B | |
| -1.85% | 106B | |
| -4.26% | 66.9B | |
| +1.39% | 49.45B | |
| +16.82% | 48B | |
| +4.06% | 40.84B | |
| +3.49% | 26.48B | |
| +0.65% | 26.25B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- POAI Stock
- News Predictive Oncology Inc.
- Transcript : Predictive Oncology Inc., Q4 2023 Earnings Call, Apr 01, 2024
